Trial intelligence / Profile preview

FDP vs FFP in Reversing Warfarin Anticoagulation in Healthy Volunteers

NCT04794348Phase 2Withdrawn

Sponsor
Teleflex
Start
May 2021
Primary completion
Mar 2022
Modality
Biologic, Plasma product
Countries
1
01

Overview

A Phase 2 trial of dried plasma, sponsored by Teleflex. Planned start May 2021; status: withdrawn.

02

Drugs

dried plasma

Beyond the preview

Go deeper on NCT04794348.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04794348.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call